• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Global Renal Denervation Market Report: 2012 Edition Product Image

Global Renal Denervation Market Report: 2012 Edition

  • ID: 2208695
  • August 2012
  • Region: Global
  • 42 Pages
  • Koncept Analytics

FEATURED COMPANIES

  • Boston Scientific
  • Covidien
  • Medtronic
  • St. Jude Medical
  • MORE

Affecting the lives of millions of people across the globe, hypertension is a chronic medical condition which substantially raises the risk of cardiac malfunction, kidney diseases and insulin resistance. However if the condition is tamed by managing the blood pressure, it suppresses the risk of occurrence of adverse events significantly. But, if it is left untreated, increases the risk of mortality from ischemic heart disease and stroke two folds.

Renal artery denervation (RDN), is a novel therapeutic paradigm meant for treating the resistant hypertension. Basically RDN is a catheter-based therapy which employs either radiofrequency or ultrasound energy for tampering the renal arteries sympathetic nerves whose hyperactivity causes treatment-resistant hypertension.

RDN devices and technologies are the most sought after innovations in the field of medical technology as they provide for an approach for managing and controlling the resistant hypertension, something that wasn’t available in the paramedics’ field before.

Developing novel medical devices using technologies which employ high frequency radiations has been a widely accepted trend these days. READ MORE >

FEATURED COMPANIES

  • Boston Scientific
  • Covidien
  • Medtronic
  • St. Jude Medical
  • MORE

1. Hypertension

1.1 Overview

BP Pattern
Essential Hypertension
Treatment Options

1.2 Global Hypertension Market

Market Overview
Procedure Growth
Market Share

1.3 The US Hypertension Market

Hypertension Prevalence
Market Opportunity

1.4 European Hypertension Market

Hypertension Prevalence
Market Opportunity

2. Renal Denervation

2.1 Overview

RDN Device Comparison
RDN Application beyond Hypertension

2.2 Renal Denervation Market

Global Market
Europe
United States
Rest of World

3. Renal Denervation - Market Dynamics

3.1 Key Trends

3.1.1 Medtronic’s HTN-3 Pivotal Study
3.1.2 Development of Novel Renal Denervation Devices
3.1.3 Devising of Baroreceptor Stimulation Technology
3.1.4 Ongoing Clinical Trials
3.1.5 Addressing the Existing Limitations of the Current Technologies

3.2 Growth Drivers

3.2.1 Increasing Cases of Hypertension
3.2.2 Increasing Expenditure on Healthcare
3.2.3 Rising Adult Population Worldwide
3.2.4 Increasing Global GNI (Gross National Income)

3.3 Challenges

3.3.1 Limitations of Invasive Technology for Treatment
3.3.2 Treatment-resistant Hypertension

4. Renal Denervation - Competitive Landscape

Competitive Overview
Renal Denervation Programs
Technology Comparison

5. Company Profiles

5.1 Medtronic

Business Overview
Financial Overview
Business Strategies
Expanding Market Share/Product Portfolio
Marketing and Distribution Tactics

5.2 St. Jude Medical

Business Overview
Financial Overview
Business Strategies
Innovative Device Fabrication
Portfolio Expansion through Acquisitions

5.3 Boston Scientific

Business Overview
Financial Overview
Business Strategies
Focus on Research & Development
Improving Financial Flexibility

5.4 Covidien

Business Overview
Financial Overview
Business Strategies
Emphasis on Innovation
Focus on Operational Excellence

6. RDN Market Outlook

Global Market
Europe
United States
Rest of World

List of Charts

BP Pattern across various Stages of Hypertension
Global Interventional Hypertension Procedures (2011-2015E)
Hypertension Prevalence in the US (2010-2015E)
Hypertension Prevalence in the Developed Europe (2010-2015E)
RDN Device Comparison – 30-Day BP Change
Worldwide RDN Procedure Share by Region (2011)
Worldwide RDN Revenue Share by Region (2011)
Rising Global Adult Population (2007-2012E)
World Gross National Income (2005-2010)
Medtronic’s Revenue Share by Business Segments (2012)
Medtronic’s Revenue and Net Earnings Analysis (2009-2012)
St. Jude Medical’s Revenue Share by Business Segments (2011)
St. Jude Medical’s Revenue and Net Earnings Analysis (2007-2011)
Boston Scientific’s Revenue Share by Business Segments (2011)
Boston Scientific’s Revenue and Net Income Analysis (2007-2011)
Covidien’s Revenue Share by Business Segments (2011)
Covidien’s Revenues and Net Income Analysis (2007-2011)
Worldwide RDN Procedure Share by Geography (2012E and 2020E)
Worldwide RDN Revenue Share by Geography (2012E and 2020E)
Global RDN Market Growth (2011-2015E)

List of Tables

Classes of Essential Hypertension
Global Interventional Hypertension Market Model
Patients Taking = 5 Hypertension Medications (2010)
U.S. Interventional Hypertension Unit Build (2010-2015E)
Developed Europe Interventional Hypertension Unit Build
Interventional Hypertension Treatment Products in Development
Global Renal Denervation Market (2011)
European Renal Denervation Market (2011)
US Renal Denervation Market (2011)
Rest of the World Renal Denervation Market (2011)
Clinical Trials for Competitive Technologies
Renal Denervation Programs
Renal Denervation Technologies
Renal Denervation Competitive Technologies Under Development
Global RDN Procedures and Revenue Forecast (2012E-2020E)
Europe RDN Procedures and Revenue Forecast (2012E-2020E)
The US RDN Procedures and Revenue Forecast (2012E-2020E)
Japan RDN Procedures and Revenue Forecast (2014E-2020E)
Rest of the World RDN Procedures and Revenue Forecast (2012E-2020E)

- Boston Scientific
- Covidien
- Medtronic
- St. Jude Medical

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos